Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100052112Phase 4Not yet recruiting
Phase 4, randomised, open-label trial of Lianhua Qingke in acute bronchitis (2 arms), sponsored by Hebei Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Median time to disease recovery. Planned start Oct 2021; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100052112.